Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome analysis of human cholangiocytes exposed to carcinogenic 1,2-dichloropropane in the presence of macrophages in vitro. | Sci Rep | 2022 | 35780190 | PubTator, text mining | PubMed |
| Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer. | BMC Cancer | 2022 | 35768832 | PubTator, text mining | PubMed |
| Upregulation of anaphase promoting complex (APC) 7 as a prognostic marker for esophageal squamous cell carcinoma: A hospital based study. | Heliyon | 2022 | 35761933 | PubTator, text mining | PubMed |
| mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations. | Noncoding RNA Res | 2022 | 35756164 | PubTator, text mining | PubMed |
| Identification of critical genes and molecular pathways in COVID-19 myocarditis and constructing gene regulatory networks by bioinformatic analysis. | PLoS One | 2022 | 35749386 | PubTator, text mining | PubMed |
| Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems. | Pharmaceutics | 2022 | 35745782 | PubTator, text mining | PubMed |
| KLF10 Functions as an Independent Prognosis Factor for Gastric Cancer. | Medicina (Kaunas) | 2022 | 35743973 | PubTator, text mining | PubMed |
| The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum. | J Clin Med | 2022 | 35743483 | PubTator, text mining | PubMed |
| Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2. | Cancers (Basel) | 2022 | 35740522 | PubTator, text mining | PubMed |
| LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway. | Cancers (Basel) | 2022 | 35740511 | PubTator, text mining | PubMed |
| SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression. | Oncol Rep | 2022 | 35730625 | PubTator, text mining | PubMed |
| Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma. | Intervirology | 2022 | 35728518 | PubTator, text mining | PubMed |
| Integrated Analysis of ECT2 and COL17A1 as Potential Biomarkers for Pancreatic Cancer. | Dis Markers | 2022 | 35722628 | PubTator, text mining | PubMed |
| Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases. | Front Pharmacol | 2022 | 35721201 | PubTator, text mining | PubMed |
| Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review. | Front Oncol | 2022 | 35712492 | PubTator, text mining | PubMed |
| A systematic review of molecular alterations in invasive non-functioning pituitary adenoma. | Endocrine | 2022 | 35711030 | PubTator, text mining | PubMed |
| LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448. | Technol Cancer Res Treat | 2022 | 35695254 | PubTator, text mining | PubMed |
| A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma. | Genes Dis | 2022 | 35685481 | PubTator, text mining | PubMed |
| Oleuropein Counteracts Both the Proliferation and Migration of Intra- and Extragonadal Seminoma Cells. | Nutrients | 2022 | 35684123 | PubTator, text mining | PubMed |
| SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells. | Int J Mol Sci | 2022 | 35682554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=27